arguing the scientific feasibility of defeating aging aubrey d.n.j. de grey chairman and cso,...

48
Arguing the scientific feasibility of defeating aging Aubrey D.N.J. de Grey Chairman and CSO, Methuselah Foundation Lorton, VA, USA and Cambridge, UK Email: [email protected]

Upload: brodie-wheelhouse

Post on 11-Dec-2015

216 views

Category:

Documents


2 download

TRANSCRIPT

Page 1: Arguing the scientific feasibility of defeating aging Aubrey D.N.J. de Grey Chairman and CSO, Methuselah Foundation Lorton, VA, USA and Cambridge, UK Email:

Arguing the scientific feasibility of defeating aging

Aubrey D.N.J. de GreyChairman and CSO, Methuselah Foundation

Lorton, VA, USA and Cambridge, UK

Email: [email protected]

MF site: http://www.methuselahfoundation.org/

Science site: http://www.sens.org/

Prize site: http://www.mprize.org/

Page 2: Arguing the scientific feasibility of defeating aging Aubrey D.N.J. de Grey Chairman and CSO, Methuselah Foundation Lorton, VA, USA and Cambridge, UK Email:

Shameless plug #1

The SENS conferences: a unique synthesis of research on technologies to repair the molecular and cellular damage of aging

- SENS 3 - Cambridge UK, Sept. 6-10 2007

http://www.sens.org/sens3/

Page 3: Arguing the scientific feasibility of defeating aging Aubrey D.N.J. de Grey Chairman and CSO, Methuselah Foundation Lorton, VA, USA and Cambridge, UK Email:

Shameless plug #2

Out Sept 4

Page 4: Arguing the scientific feasibility of defeating aging Aubrey D.N.J. de Grey Chairman and CSO, Methuselah Foundation Lorton, VA, USA and Cambridge, UK Email:

Background

- Focus on “giving life to years” is >60y old

- It hasn’t delivered adequate public funding

- Even when absurdly exaggerated (“C of M”)

- Or illogically described (“HA”, “A not a D”)

- It’s high time we tried something different

- Is the Longevity Dividend initiative the answer?

Page 5: Arguing the scientific feasibility of defeating aging Aubrey D.N.J. de Grey Chairman and CSO, Methuselah Foundation Lorton, VA, USA and Cambridge, UK Email:

Why I’m pessimistic about LD (though I do strongly support it!)

Since the mid-1960s, the USA has seen:

- ~7y increase in life expectancy

- improvement in public health

- extension of the period of health and vigour

- reduction in frailty and disability at all ages

- no compression of severe morbidity

- a subtler LD than Olshansky et al describe

Page 6: Arguing the scientific feasibility of defeating aging Aubrey D.N.J. de Grey Chairman and CSO, Methuselah Foundation Lorton, VA, USA and Cambridge, UK Email:

“How’s it going to be done?”Len Hayflick, Australia, 2006 (rhetorically?)

“We don’t know;we don’t need to know”

SJO’s response

Correct - up to a point…

Page 7: Arguing the scientific feasibility of defeating aging Aubrey D.N.J. de Grey Chairman and CSO, Methuselah Foundation Lorton, VA, USA and Cambridge, UK Email:

What if……- a demographer,

- a geriatrician,

- a lobbyist,

- and a biogerontologist uniformly described by his colleagues as problematically dogmatic

…are wrong about what’s realistic?

Page 8: Arguing the scientific feasibility of defeating aging Aubrey D.N.J. de Grey Chairman and CSO, Methuselah Foundation Lorton, VA, USA and Cambridge, UK Email:

As I claim…

The first 1000-year-old is probably less than 20 years younger than the first 150-

year-old

Page 9: Arguing the scientific feasibility of defeating aging Aubrey D.N.J. de Grey Chairman and CSO, Methuselah Foundation Lorton, VA, USA and Cambridge, UK Email:

Similarly…

The first 1000y-LE cohort is probably less than

20 years younger than the first 100y-

LE cohort

Page 10: Arguing the scientific feasibility of defeating aging Aubrey D.N.J. de Grey Chairman and CSO, Methuselah Foundation Lorton, VA, USA and Cambridge, UK Email:

Radical LE: Topics

- The key credibility challenges:

- Argument from personal incredulity

- Argument from self-serving authority

- The key solutions

- Demystifying the task

- Achieving interim results

Page 11: Arguing the scientific feasibility of defeating aging Aubrey D.N.J. de Grey Chairman and CSO, Methuselah Foundation Lorton, VA, USA and Cambridge, UK Email:

Radical LE: Topics

- The key credibility challenges:

- Argument from personal incredulity

- Argument from self-serving authority

- The key solutions

- Demystifying the task

- Achieving interim results

Page 12: Arguing the scientific feasibility of defeating aging Aubrey D.N.J. de Grey Chairman and CSO, Methuselah Foundation Lorton, VA, USA and Cambridge, UK Email:

Aging in a nutshell

Metabolism ongoingly causes “damage”

and

Damage eventually causes pathology

Page 13: Arguing the scientific feasibility of defeating aging Aubrey D.N.J. de Grey Chairman and CSO, Methuselah Foundation Lorton, VA, USA and Cambridge, UK Email:

Options for intervention

Gerontology Engineering Geriatrics

Metabolism Damage Pathology

Claim: unlike the others, the “engineering” approach can probably achieve substantial extension of human healthspan quite soon

Page 14: Arguing the scientific feasibility of defeating aging Aubrey D.N.J. de Grey Chairman and CSO, Methuselah Foundation Lorton, VA, USA and Cambridge, UK Email:

Age

Reserve

00

max

frail

The simple logic of LEV

Fixing half the damage, then 3/4, then 7/8…. - outpaces the so-far-unfixable damage…

- maintains healthspan indefinitely

Page 15: Arguing the scientific feasibility of defeating aging Aubrey D.N.J. de Grey Chairman and CSO, Methuselah Foundation Lorton, VA, USA and Cambridge, UK Email:

Robust human rejuvenation (RHR)

Addition of 30 extra years of healthy life (and total life) to

people who are already in middle age when treatment is begun

Page 16: Arguing the scientific feasibility of defeating aging Aubrey D.N.J. de Grey Chairman and CSO, Methuselah Foundation Lorton, VA, USA and Cambridge, UK Email:

Longevity escape velocity (LEV)

The rate at which rejuvenation therapies must improve (following achievement of RHR) in order to outpace the accumulation of

so-far-irreparable damage

Page 17: Arguing the scientific feasibility of defeating aging Aubrey D.N.J. de Grey Chairman and CSO, Methuselah Foundation Lorton, VA, USA and Cambridge, UK Email:

Is this rate of progress plausible?

Data1903 1927

1949 1969

Page 18: Arguing the scientific feasibility of defeating aging Aubrey D.N.J. de Grey Chairman and CSO, Methuselah Foundation Lorton, VA, USA and Cambridge, UK Email:

Simulating aging(Phoenix & de Grey, AGE, in press)

Metabolism ongoingly causes “damage”

and

Damage eventually causes pathologySo….

Simulations of aging (and intervention) should simulate damage accumulation

Page 19: Arguing the scientific feasibility of defeating aging Aubrey D.N.J. de Grey Chairman and CSO, Methuselah Foundation Lorton, VA, USA and Cambridge, UK Email:

Simulating damage: modelStructural parameters

N_CAT: The number of damage categories each person has N_MECH: The number of mechanisms in each category

MECH_WEIGHTm: The contribution of a mechanism to a category

Fitting parameters

BASAL_M: The mean basal damage rate BASAL_SD: The standard deviation of the basal damage rate

BASAL_H: The homogeneity of basal damage rate in a single person EXP_M: The mean exponential damage rate

EXP_SD: The standard deviation of the exponential damage rate

EXP_H: The homogeneity of exponential damage rate in a single person

FATAL_M: The mean yearly challenge FATAL_SD: The standard deviation of the yearly challenge

Values set for each person at initialisation:

PB: Basal rate for the person: lognorm(BASAL_M, BASAL_SD)

PE: Exponential rate for the person: lognorm(EXP_M, EXP_SD)

MBc,m:Basal rate for each mechanism: lognorm(BASAL_M, BASAL_SD)*(1-BASAL_H) + PB*BASAL_H

MEc,m: Exponential rate for each mechanism: lognorm(EXP_M, EXP_SD)*(1-EXP_H) + PE*EXP_H

D_Mc,m : Cumulative damage for each mechanism: 0 D_Cc : Cumulative damage for each category: 0

Variables updated for each person at each time step (year):

Total damage: PD(t) = [SUM c=1..N_CAT] D_Cc(t) Damage increment: DI_Mc,m(t) = MBc,m + MEc,m*PD(t-1)

Cumulative damage: D_Mc,m(t) = DI_Mc,m(t) + D_Mc,m(t-1)

Cumulative category damage: D_Cc(t) = [SUM m=1..N_MECH] DI_Mc,m(t)

Fatality challenge: FATAL(t) = |norm(FATAL_M, FATAL_SD)|

If D_Cc(t) > FATAL(t) for any c, the person dies at age t

Page 20: Arguing the scientific feasibility of defeating aging Aubrey D.N.J. de Grey Chairman and CSO, Methuselah Foundation Lorton, VA, USA and Cambridge, UK Email:

Results: LEV in practiceTherapies doubling in efficacy every 42 y

0 50 100 150 200 250 300 350

Page 21: Arguing the scientific feasibility of defeating aging Aubrey D.N.J. de Grey Chairman and CSO, Methuselah Foundation Lorton, VA, USA and Cambridge, UK Email:

Question

When simple and unchallenged logic leads to counterintuitive conclusions, is it more effective in the long run to

ignore/suppress/deny those conclusions, or to point them out?

Page 22: Arguing the scientific feasibility of defeating aging Aubrey D.N.J. de Grey Chairman and CSO, Methuselah Foundation Lorton, VA, USA and Cambridge, UK Email:

LD’s key vulnerability- yes, modest LE sounds realistic

- yes, modest LE sounds un-scary

BUT- maybe not un-scary enough

- hard questions will precede money

- “won’t this just fuel the LE fire?”

- “what happened to ‘aging not a disease’?”

Page 23: Arguing the scientific feasibility of defeating aging Aubrey D.N.J. de Grey Chairman and CSO, Methuselah Foundation Lorton, VA, USA and Cambridge, UK Email:

Radical LE: Topics

- The key credibility challenges:

- Argument from personal incredulity

- Argument from self-serving authority

- The key solutions

- Demystifying the task

- Achieving interim results

Page 24: Arguing the scientific feasibility of defeating aging Aubrey D.N.J. de Grey Chairman and CSO, Methuselah Foundation Lorton, VA, USA and Cambridge, UK Email:

Giving the middle-aged 30 years of extra healthy life: Robust Human Rejuvenation

Damage rising with age It or its effects reversible by

Cell loss, cell atrophy Cell therapy, mainly

Extracellular junk Phagocytosis by immune stimulation

Extracellular crosslinks AGE-breaking molecules/enzymes

Death-resistant cells Suicide genes, immune stimulation

Mitochondrial mutations Allotopic expression of 13 proteins

Intracellular junk Transgenic microbial hydrolasesNuclear [epi]mutations (only cancer matters)

Telomerase/ALT gene deletion plus periodic stem cell reseeding

Page 25: Arguing the scientific feasibility of defeating aging Aubrey D.N.J. de Grey Chairman and CSO, Methuselah Foundation Lorton, VA, USA and Cambridge, UK Email:

7-KC degradation - presented at meetings

Page 26: Arguing the scientific feasibility of defeating aging Aubrey D.N.J. de Grey Chairman and CSO, Methuselah Foundation Lorton, VA, USA and Cambridge, UK Email:

First MF-funded paper submitted

Page 27: Arguing the scientific feasibility of defeating aging Aubrey D.N.J. de Grey Chairman and CSO, Methuselah Foundation Lorton, VA, USA and Cambridge, UK Email:

Radical LE: Topics

- The key credibility challenges:

- Argument from personal incredulity

- Argument from self-serving authority

- The key solutions

- Demystifying the task

- Achieving interim results

Page 28: Arguing the scientific feasibility of defeating aging Aubrey D.N.J. de Grey Chairman and CSO, Methuselah Foundation Lorton, VA, USA and Cambridge, UK Email:

Which is the odd one out?

“laughable claim...arrant nonsense”

“this is worthless nonsense”

“It can’t be done”

Page 29: Arguing the scientific feasibility of defeating aging Aubrey D.N.J. de Grey Chairman and CSO, Methuselah Foundation Lorton, VA, USA and Cambridge, UK Email:

“The BBC … earnestly reported a few months ago the laughable claim that

the first human who will live to 1,000 years is 60 already.

If even Auntie, as the BBC is affectionately known, can succumb to such arrant nonsense, what hope is there for the more excitable sections of the media?”

Tom Kirkwood, 2005, writing in Nature

Page 30: Arguing the scientific feasibility of defeating aging Aubrey D.N.J. de Grey Chairman and CSO, Methuselah Foundation Lorton, VA, USA and Cambridge, UK Email:

“There are four stages of acceptance:

i) this is worthless nonsense;

ii) this is an interesting, but perverse, point of view;

iii) this is true, but quite unimportant;

iv) I always said so.”J.B.S. Haldane, 1963

Page 31: Arguing the scientific feasibility of defeating aging Aubrey D.N.J. de Grey Chairman and CSO, Methuselah Foundation Lorton, VA, USA and Cambridge, UK Email:

“New ideas pass through three periods:

1) It can’t be done.

2) It probably can be done, but it’s not worth doing.

3) I knew it was a good idea all along!”

Arthur C. Clarke, 1968

Page 32: Arguing the scientific feasibility of defeating aging Aubrey D.N.J. de Grey Chairman and CSO, Methuselah Foundation Lorton, VA, USA and Cambridge, UK Email:

Hypothesis

“the SENS agenda is easily recognized as a pretence by those with scientific experience”

28 eminent gerontologists, November 2005EMBO Reports 6:1006

Page 33: Arguing the scientific feasibility of defeating aging Aubrey D.N.J. de Grey Chairman and CSO, Methuselah Foundation Lorton, VA, USA and Cambridge, UK Email:

Experimenters

Page 34: Arguing the scientific feasibility of defeating aging Aubrey D.N.J. de Grey Chairman and CSO, Methuselah Foundation Lorton, VA, USA and Cambridge, UK Email:

Experiment- Induce critics to give their reasons in writing

- Ask a panel of neutral experts what they think

Craig Venter (needs no intro)Rod Brooks (head, MIT AI lab)

Nathan Myhrvold (ex-CTO, Microsoft)Vikram Kumar (Harvard/MIT medic)Anita Goel (Harvard medic/physicist)

Page 35: Arguing the scientific feasibility of defeating aging Aubrey D.N.J. de Grey Chairman and CSO, Methuselah Foundation Lorton, VA, USA and Cambridge, UK Email:

ReagentsLife Extension Pseudoscience and the SENS Plan

(7000 words)Preston W. Estep, Matt Kaeberlein, Pankaj Kapahi, Brian K. Kennedy,

Gordon J. Lithgow, George M. Martin, Simon Melov, R. Wilson Powers III, Heidi A. Tissenbaum

“1) SENS is based on the scientifically unsupported speculations of Aubrey de Grey, which are camouflaged by the legitimate science of others; 2) SENS bears only a superficial resemblance to science or engineering; 3) SENS and de Grey’s writings in support of it are riddled with jargonfilled misunderstandings and misrepresentations; 4) SENS’s notoriety is due almost entirely to its emotional appeal; 5) SENS is pseudoscience.”

Page 36: Arguing the scientific feasibility of defeating aging Aubrey D.N.J. de Grey Chairman and CSO, Methuselah Foundation Lorton, VA, USA and Cambridge, UK Email:

Result“They are too quick to engage in name-calling, labeling

ideas as ‘pseudoscientific’ or ‘unscientific’ that they cannot really demonstrate are so.”

“SENS is a collection of hypotheses that … cannot rise to the level of being scientifically verified. However, by the same token, the ideas of SENS have not been conclusively disproved.”

“I have no confidence that they understand engineering, and some of their criticisms are poor criticisms of a legitimate engineering process.”

Page 37: Arguing the scientific feasibility of defeating aging Aubrey D.N.J. de Grey Chairman and CSO, Methuselah Foundation Lorton, VA, USA and Cambridge, UK Email:

Hypothesis

“the SENS agenda is easily recognized as a pretence by those with scientific experience”

28 eminent gerontologists, November 2005EMBO Reports 6:1006

Page 38: Arguing the scientific feasibility of defeating aging Aubrey D.N.J. de Grey Chairman and CSO, Methuselah Foundation Lorton, VA, USA and Cambridge, UK Email:

QuestionWhy are grandees, others skeptical?

- evidently not for scientific reasons

- sustained refusal to learn key data

- fixation on own prestige, funding

- grandees espouse one’s prior view

- grandees espouse comforting view

Page 39: Arguing the scientific feasibility of defeating aging Aubrey D.N.J. de Grey Chairman and CSO, Methuselah Foundation Lorton, VA, USA and Cambridge, UK Email:

Question

How are grandees skeptical?- lunge for cerebral off-switch

“they stress my failure to note that no SENS intervention—in isolation—has ever been shown to extend any organism’s lifespan. I do not recall Henry Ford alerting potential customers that the components of a car—in isolation—remain obstinately stationary when burning petrol is poured on them, nor do I recall his being castigated for this omission.”

Page 40: Arguing the scientific feasibility of defeating aging Aubrey D.N.J. de Grey Chairman and CSO, Methuselah Foundation Lorton, VA, USA and Cambridge, UK Email:

A familiar exchange“Where’s your data?”

“I just showed you my data”

“That’s not relevant data”

“Who says?”

“Well it’s just you saying it’s relevant”

“No, I’m also saying why”

“Well I want lifespan data”

“Bzzzt! - API, ASA”

Page 41: Arguing the scientific feasibility of defeating aging Aubrey D.N.J. de Grey Chairman and CSO, Methuselah Foundation Lorton, VA, USA and Cambridge, UK Email:

Will 7y LE bring a dividend?

- 40 years ago, Western LE was ~7 years shorter

- Medical expenditure has not precisely fallen

- Why should the next 7y rise be different?

- NOT because we’ll combat “aging” - frailspan has held steady. Slope vs intercept not the issue

- However, the economy benefited anyway!

- Hence, focus should be on what WON’T work

Page 42: Arguing the scientific feasibility of defeating aging Aubrey D.N.J. de Grey Chairman and CSO, Methuselah Foundation Lorton, VA, USA and Cambridge, UK Email:

LD’s key vulnerability- yes, modest LE sounds realistic

- yes, modest LE sounds un-scary

BUT- maybe not un-scary enough

- hard questions will precede money

- “won’t this just fuel the LE fire?”

- “what happened to ‘aging not a disease’?”

Page 43: Arguing the scientific feasibility of defeating aging Aubrey D.N.J. de Grey Chairman and CSO, Methuselah Foundation Lorton, VA, USA and Cambridge, UK Email:

Unavoidable, and useful, facts

- Lack of speed (in combating aging) kills

- Aging will be just as bad when LE is 90

- The demystification option is working

- Warm words are cheap; ultimately policy follows, not leads, the electorate

- Fear of the facts (API, ASA) never works

Page 44: Arguing the scientific feasibility of defeating aging Aubrey D.N.J. de Grey Chairman and CSO, Methuselah Foundation Lorton, VA, USA and Cambridge, UK Email:

Back to first principles

- Most people are irrational about aging

- This was for good psychological reasons

- Thus, mealy-mouthed messaging is futile

- Demystification is a serious alternative

- It will be hastened by experts’ objectivity

Page 45: Arguing the scientific feasibility of defeating aging Aubrey D.N.J. de Grey Chairman and CSO, Methuselah Foundation Lorton, VA, USA and Cambridge, UK Email:

“I want the old Aubrey back”Jay Olshansky

“Do You Want to Live Forever?”

“Old Aubrey”: harmless theoretician who wasn’t even thinking about intervention, let alone talking about it, so wasn’t threatening grandees’ quiet lives

“New Aubrey”: dangerous activist who exposes grandees’ dirty little secrets about how little they really know (or care?) about options for intervention

Which is really preferable???

Page 46: Arguing the scientific feasibility of defeating aging Aubrey D.N.J. de Grey Chairman and CSO, Methuselah Foundation Lorton, VA, USA and Cambridge, UK Email:
Page 47: Arguing the scientific feasibility of defeating aging Aubrey D.N.J. de Grey Chairman and CSO, Methuselah Foundation Lorton, VA, USA and Cambridge, UK Email:

Age

Reserve

00

max

frail

LEV decreases with time

Fixing half the damage, then 2/3, then 3/4…. - still good enough…

- just like gravitational escape velocity

Page 48: Arguing the scientific feasibility of defeating aging Aubrey D.N.J. de Grey Chairman and CSO, Methuselah Foundation Lorton, VA, USA and Cambridge, UK Email:

Data